
Anders Aune Tveita
- Researcher; MD, PhD
- +47 938 78 598
Publications 2020
CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages
Blood Adv, 4 (12), 2595-2605
DOI 10.1182/bloodadvances.2020001434, PubMed 32544236
Komplikasjoner og dødelighet blant pasienter innlagt med covid-19
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0432, PubMed 32815354
COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital
Tidsskr Nor Laegeforen, 140 (7)
DOI 10.4045/tidsskr.20.0301, PubMed 32378844
National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study
Scand J Trauma Resusc Emerg Med, 28 (1), 66
DOI 10.1186/s13049-020-00764-3, PubMed 32660623
Rettelse: Lungeembolisme ved covid-19
Tidsskr Nor Laegeforen, 140 (1)
DOI 10.4045/tidsskr.20.0987, PubMed 33433107
Pulmonary embolism in cases of COVID-19
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.20.0366, PubMed 32463186
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
Commun Biol, 3 (1), 196
DOI 10.1038/s42003-020-0916-2, PubMed 32332858
Publications 2019
Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
NPJ Vaccines, 4, 9
DOI 10.1038/s41541-019-0101-0, PubMed 30775000
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
Cancer Immunol Immunother, 68 (11), 1865-1873
DOI 10.1007/s00262-019-02374-0, PubMed 31448380
Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity
Cancer Res, 79 (7), 1624-1634
DOI 10.1158/0008-5472.CAN-18-2867, PubMed 30692215
B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells
Proc Natl Acad Sci U S A, 116 (51), 25850-25859
DOI 10.1073/pnas.1902836116, PubMed 31796587
Publications 2018
Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
Front Immunol, 9, 1684
DOI 10.3389/fimmu.2018.01684, PubMed 30083157
CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
Cancer Res, 78 (16), 4573-4585
DOI 10.1158/0008-5472.CAN-17-2426, PubMed 29752262
Publications 2017
Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
Front Immunol, 8, 667
DOI 10.3389/fimmu.2017.00667, PubMed 28642760
Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice
Leukemia, 31 (10), 2114-2121
DOI 10.1038/leu.2017.69, PubMed 28232741
Publications 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, 12 (1), 1-222
DOI 10.1080/15548627.2015.1100356, PubMed 26799652
Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display
Oncotarget, 7 (41), 67175-67182
DOI 10.18632/oncotarget.11946, PubMed 27626487
Publications 2015
Idiotype-specific CD4(+) T cells eradicate disseminated myeloma
Leukemia, 30 (5), 1216-20
DOI 10.1038/leu.2015.278, PubMed 26449664
Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens
Cancer Res, 75 (16), 3268-78
DOI 10.1158/0008-5472.CAN-14-3640, PubMed 26038231
Publications 2014
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus
Eur J Immunol, 45 (2), 624-35
DOI 10.1002/eji.201445080, PubMed 25410055
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Front Immunol, 5, 174
DOI 10.3389/fimmu.2014.00174, PubMed 24782871
Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells
J Immunol, 192 (9), 4174-83
DOI 10.4049/jimmunol.1302359, PubMed 24706724
Limitations of bystander killing in Th1/M1 immune responses against a secreted tumor antigen
Oncoimmunology, 3 (9), e954953
DOI 10.4161/21624011.2014.954953, PubMed 25941607
Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
Eur J Immunol, 44 (9), 2625-37
DOI 10.1002/eji.201444659, PubMed 24846412
Publications 2012
Myocardial gene expression profiling of rewarming shock in a rodent model of accidental hypothermia
Cryobiology, 64 (3), 201-10
DOI 10.1016/j.cryobiol.2012.01.009, PubMed 22330979
Publications 2011
Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development
Arthritis Rheum, 63 (2), 513-22
DOI 10.1002/art.30116, PubMed 21280006
Publications 2010
The danger model in deciphering autoimmunity
Rheumatology (Oxford), 49 (4), 632-9
DOI 10.1093/rheumatology/keq004, PubMed 20144928
Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis
PLoS One, 5 (8)
DOI 10.1371/journal.pone.0012096, PubMed 20856893
Publications 2009
Development of lupus nephritis is associated with qualitative changes in the glomerular collagen IV matrix composition
Lupus, 18 (4), 355-60
DOI 10.1177/0961203308100842, PubMed 19276304
Publications 2008
Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis
Arthritis Res Ther, 10 (6), 229
DOI 10.1186/ar2532, PubMed 19090960
Increased glomerular matrix metalloproteinase activity in murine lupus nephritis
Kidney Int, 74 (9), 1150-8
DOI 10.1038/ki.2008.308, PubMed 18596727